Behavioural management of antipsychotic-induced weight gain: a review

被引:36
|
作者
Werneke, U
Taylor, D
Sanders, TA
Wessely, S
机构
[1] Inst Psychiat, Ctr Econ Mental Hlth, London, England
[2] Maudsley Hosp & Inst Psychiat, Dept Pharm, London SE5 8AZ, England
[3] Kings Coll London, Dept Nutr & Dietet, London WC2R 2LS, England
[4] Kings Coll London, Sch Med & Dent, Acad Dept Psychol Med, London WC2R 2LS, England
关键词
weight gain; atypical antipsychotics; diet; exercise; review; randomized controlled trial;
D O I
10.1034/j.1600-0447.2003.00190.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Objective: Although psychiatrists are aware of weight gain induced by atypical antipsychotics, only few studies on behavioural interventions in this patient group are published. T his review aims to summarize the evidence on effectiveness of behavioural interventions for weight gain in the general population and in-patients treated with atypical antipsychotics. Method: Medline and Cochrane databases search for evidence on effectiveness of behavioural interventions. Results: In general, behavioural approaches including, diet, exercise and drug treatments may be effective. There were only 13 studies of behavioural interventions for patients taking antipsychotic medication. No study met the criteria for a RCT. Calorie restriction in a controlled ward environment, structured counselling combined with cognitive behavioural therapy and counselling on life style and provision of rewards may potentially lead to weight loss. Conclusion: Currently only limited, methodologically. awed, evidence is available that behavioural interventions in overweight patients treated with antipsychotics, although intuitively appealing, actually work.
引用
收藏
页码:252 / 259
页数:8
相关论文
共 50 条
  • [21] Management of atypical antipsychotic-induced weight gain in schizophrenic patients with topiramate
    Lin, YH
    Liu, CY
    Hsiao, MC
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (05) : 613 - 615
  • [22] Pharmacogenetic Tests for Antipsychotic-Induced Weight Gain
    Zhuravleva, E. O.
    Velts, N. Yu
    Snegireva, I. I.
    Kutekhova, G., V
    Alyautdin, R. N.
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2019, 53 (07) : 668 - 671
  • [23] Antipsychotic-induced weight gain in patients with schizophrenia
    Venkatasubramanian, Ganesan
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (16): : 1899 - 1899
  • [24] Antipsychotic-induced weight gain: The role of the genetics
    Yazici, Kemal
    Yazici, Aylin
    KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2008, 18 (01): : 59 - 70
  • [25] An animal model of antipsychotic-induced weight gain
    Arjona, AA
    Zhang, SX
    Adamson, B
    Wurtman, RJ
    BEHAVIOURAL BRAIN RESEARCH, 2004, 152 (01) : 121 - 127
  • [26] Pilot Trial of Contingency Management For the Treatment of Antipsychotic-Induced Weight Gain
    Ratliff, Joseph C.
    Palmese, Laura B.
    Tonizzo, Kamile M.
    Reutenauer, Erin L.
    Tek, Cenk
    OBESITY, 2011, 19 : S99 - S100
  • [27] Antipsychotic-induced weight gain in antipsychotic-naive adolescents
    Parellada, M.
    Fraguas, D.
    Ruiz-Sancho, A.
    Moreno, D.
    Cifuentes, A.
    Ulloa, A.
    Lozano, R.
    Arango, C.
    SCHIZOPHRENIA BULLETIN, 2007, 33 (02) : 452 - 452
  • [28] Pharmacogenetic testing to predict antipsychotic-induced weight gain: a systematic review
    Risselada, Arne J.
    Mulder, Hans
    Heerdink, Eibert R.
    Egberts, Toine C. G.
    PHARMACOGENOMICS, 2011, 12 (08) : 1213 - 1227
  • [29] PHARMACOGENETICS OF ANTIPSYCHOTIC-INDUCED WEIGHT GAIN IN SCHIZOPHRENIC PATIENTS
    Musil, R.
    Spellmann, I.
    Riedel, M.
    Rospleszcz, S.
    Borck, A.
    Falkai, P.
    Zill, P.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [30] Antipsychotic pitfalls: idiopathic intracranial hypertension and antipsychotic-induced weight gain
    Namiki, Hirofumi
    BMJ CASE REPORTS, 2020, 13 (06)